Skip to main content

Preoperative Cardiac Assessment: A Practical, Evidence-Based Guide for Clinicians



Preoperative Cardiac Assessment: A Practical, Evidence-Based Guide for Clinicians

Preoperative cardiac assessment is a critical step in ensuring safe surgery. Cardiovascular complications remain a major cause of perioperative morbidity and mortality, especially in patients with known or suspected heart disease. A systematic, guideline-based approach helps clinicians stratify risk, optimize patients, and communicate effectively with surgical teams.


This article provides a practical, step-by-step framework based on current recommendations (ACC/AHA, ESC), written in simple, clinical language for quick application.

---

πŸ” Why Preoperative Cardiac Assessment Matters


Surgery induces physiologic stress (tachycardia, increased myocardial oxygen demand).


Anaesthesia can cause hypotension, arrhythmias, and mask symptoms.


Many patients with cardiovascular risk factors remain undiagnosed until exposed to perioperative stress.


A structured assessment helps:

✓ Identify high-risk patients

✓ Reduce avoidable cancellations

✓ Optimize outcomes through medical therapy or intervention




---


1️⃣ Step 1: Determine Urgency of Surgery


πŸ₯ Emergency


No time for extensive testing.


Stabilize life-threatening issues (e.g., arrhythmia, pulmonary edema).


Proceed to surgery with best possible medical management.


⏳ Time-sensitive (Urgent)


Limited optimization possible.


Perform focused assessment.



πŸ“… Elective


Full workup possible.


Opportunity to adjust medications, perform tests, or treat unstable conditions.




---


2️⃣ Step 2: Look for Active Cardiac Conditions (Must Be Stabilized First)


If present, postpone elective surgery and treat:


Unstable angina


Recent MI (<30 days)


Decompensated heart failure


Significant arrhythmias (AF with RVR, VT, complete heart block)


Severe valvular disease (critical AS, symptomatic MR/MS)




---


3️⃣ Step 3: Assess Functional Capacity (METs)


Functional capacity is one of the strongest predictors of perioperative safety.


πŸ‘‰ Good (≥4 METs)


Patient can climb 2 flights of stairs, walk briskly, or perform normal housework.

Usually no further cardiac testing needed.


πŸ‘‰ Poor (<4 METs)


Limited exercise tolerance → higher risk.

Consider stress testing if surgery is high-risk.



---


4️⃣ Step 4: Evaluate Surgery-Specific Cardiac Risk


Low Risk (<1%)


Cataract surgery


Superficial procedures


Minor orthopedic



→ No further testing.


Intermediate Risk (1–5%)


Intraperitoneal


Orthopedic major


Head & neck


Urologic



High Risk (>5%)


Major vascular surgery


Aortic or peripheral arterial


Prolonged or combined procedures




---


5️⃣ Step 5: Review Patient-Specific Risk Factors


Age >70


CAD / prior MI


Heart failure


Stroke / TIA


Diabetes (especially insulin use)


CKD


Hypertension


Smoking / obesity



Use validated calculators:

RCRI (Revised Cardiac Risk Index), NSQIP, ACS Surgical Risk Calculator.



---


6️⃣ Step 6: Decide Whether Noninvasive Testing Is Needed


Only do tests if results will change management.


πŸ’“ Stress Testing


Indicated when:


Functional capacity <4 METs and


Surgery is intermediate/high risk and


Patient has ≥1 clinical risk factor



Not indicated for low-risk surgery.


🩺 Echocardiography


Indications:


New or worsening dyspnea


Known HF with poor control


Known valvular disease with no echo in last 1 year


Murmur + symptoms



Not for routine screening.


πŸ“Œ ECG


Indicated for:


Age >45–50


Known cardiac disease


Intermediate/high-risk surgery



πŸ§ͺ Cardiac Biomarkers (BNP/NT-proBNP, Troponin)


Useful in:


Age >65


≥1 clinical risk factor


High-risk surgery




---


7️⃣ Step 7: Optimize Medical Therapy


🩸 Beta-blockers


Continue if already prescribed.

Start only if strongly indicated; begin at least 1 week before surgery.


⚡ ACE inhibitors/ARBs


Hold morning of surgery to avoid hypotension (unless used for HF).



πŸ’Š Statins


Continue; consider starting for vascular surgery.


πŸ’‰ Antiplatelets


Continue aspirin for high-risk CAD unless bleeding risk outweighs benefit.


Hold clopidogrel 5–7 days preop (unless recent stent).



πŸ’š Heart Failure


Ensure euvolemia


Adjust diuretics carefully


Treat exacerbations before surgery




---


8️⃣ Step 8: Special Conditions


Coronary Stents


Bare-metal stent: minimum 30 days before elective surgery


Drug-eluting stent:


Newer DES: minimum 3 months


Earlier-generation: 6 months




Valvular Disease


Severe AS requires evaluation ± TAVR/AVR before major surgery.


Severe MR/MS → optimize volume, consider echo.



Arrhythmias


Control rate in AF


Treat electrolyte abnormalities


Address syncope history



Heart Failure


One of the strongest predictors of perioperative events


Ensure maximally optimized GDMT




---


9️⃣ Step 9: Perioperative Monitoring & Communication


For intermediate/high-risk patients → consider telemetry


If BNP/Troponin elevated → postoperative monitoring of troponins


Clear communication between cardiology, anesthesia, and surgery team is essential




---


πŸ”š Key Takeaways


Not every patient needs testing — risk-driven approach saves time and avoids delays.


Stabilize active cardiac conditions before elective surgery.


Functional capacity (METs) remains the strongest predictor.


Most testing is unnecessary for low-risk surgeries.


Optimize medications, especially beta-blockers and statins.


Use objective tools (RCRI, NSQIP) to stratify risk.

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...